» Articles » PMID: 36292406

Risk Prediction Performance of the Thai Cardiovascular Risk Score for Mild Cognitive Impairment in Adults with Metabolic Risk Factors in Thailand

Abstract

Individuals with metabolic risks are at high risk of cognitive impairment. We aimed to investigate whether the Thai Cardiovascular Risk (TCVR) score can be used to predict mild cognitive impairment (MCI) in Thai adults with metabolic risks. The study was conducted using secondary data of patients with metabolic risks from Maharaj Nakorn Chiang Mai Hospital. MCI was indicated by an MoCA score of less than 25. Six different TCVR models were used with various combinations of ten different variables for predicting the risk of MCI. The area under the receiver operator characteristic curve (AuROC) and Hosmer-Lemeshow goodness of fit tests were used for determining discriminative performance and model calibration. The sensitivity of the discriminative performance was further evaluated by stratifying by age and gender. From a total of 421 participants, 348 participants had MCI. All six TCVR models showed a similar AuROC, varying between 0.58 and 0.61. The anthropometric-based model showed the best risk prediction performance in the older age group (AuROC 0.69). The laboratory-based model provided the highest discriminative performance for the younger age group (AuROC 0.60). There is potential for the development of an MCI risk model based on values from routine cardiovascular risk assessments among patients with metabolic risks.

Citing Articles

Proteomic associations with cognitive variability as measured by the Wisconsin Card Sorting Test in a healthy Thai population: A machine learning approach.

Chen C, Khanthiyong B, Thaweetee-Sukjai B, Charoenlappanit S, Roytrakul S, Surit P PLoS One. 2025; 20(2):e0313365.

PMID: 39977438 PMC: 11841870. DOI: 10.1371/journal.pone.0313365.


Examining determinants of control of metabolic syndrome among older adults with NCDs receiving service at NCD Plus clinics: multilevel analysis.

Suapumee N, Seeherunwong A, Wanitkun N, Chansatitporn N BMC Health Serv Res. 2024; 24(1):1118.

PMID: 39334103 PMC: 11429379. DOI: 10.1186/s12913-024-11562-3.


A household survey of the prevalence of subjective cognitive decline and mild cognitive impairment among urban community-dwelling adults aged 30 to 65.

Pinyopornpanish K, Buawangpong N, Soontornpun A, Thaikla K, Pateekhum C, Nantsupawat N Sci Rep. 2024; 14(1):7783.

PMID: 38565884 PMC: 10987517. DOI: 10.1038/s41598-024-58150-3.


Cardiovascular disease risk models and dementia or cognitive decline: a systematic review.

Jia R, Wang Q, Huang H, Yang Y, Chung Y, Liang T Front Aging Neurosci. 2023; 15:1257367.

PMID: 37904838 PMC: 10613491. DOI: 10.3389/fnagi.2023.1257367.


Prevention, Intervention and Care of Neurodegenerative Diseases.

Bakirtzis C, Boziki M, Grigoriadis N Healthcare (Basel). 2023; 11(16).

PMID: 37628546 PMC: 10454199. DOI: 10.3390/healthcare11162349.

References
1.
Amihaesei I, Chelaru L . Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview. Rev Med Chir Soc Med Nat Iasi. 2015; 118(4):896-900. View

2.
Hoo Z, Candlish J, Teare D . What is an ROC curve?. Emerg Med J. 2017; 34(6):357-359. DOI: 10.1136/emermed-2017-206735. View

3.
Ronnemaa E, Zethelius B, Lannfelt L, Kilander L . Vascular risk factors and dementia: 40-year follow-up of a population-based cohort. Dement Geriatr Cogn Disord. 2011; 31(6):460-6. DOI: 10.1159/000330020. View

4.
Gylling H, Strandberg T, Tilvis R, Miettinen T . Regulation of serum cholesterol level in middle-aged and elderly men. Relation of cholesterol absorption and synthesis to lipoprotein metabolism. Arterioscler Thromb. 1994; 14(5):694-700. DOI: 10.1161/01.atv.14.5.694. View

5.
Pinyopornpanish K, Chattipakorn N, Chattipakorn S . Lipocalin-2: Its perspectives in brain pathology and possible roles in cognition. J Neuroendocrinol. 2019; 31(10):e12779. DOI: 10.1111/jne.12779. View